arrow
F

Federica Pezzuto

university of padova medical school
H指数:20
被引数:2,046

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Artificial intelligence-based assessment of tumor bed stroma in non-small cell lung cancer after neoadjuvant therapy: Association with pathologic response and survival. A multicenter study

基于人工智能对非小细胞肺癌新辅助治疗后肿瘤床间质的评估:与病理反应和生存期的关联。一项多中心研究

2026-09-010
PRE
Revised demicco score improves prediction of postoperative recurrence in pleural solitary fibrous tumours: A multicenter retrospective study

修订后的demicco评分提高了胸膜孤立性纤维瘤术后复发的预测:一项多中心回顾性研究

EJSO
IF2.9
2026-08-010
PRE
CHIMERA: a phase II study of neoadjuvant pembrolizumab in combination with cisplatin or carboplatin and pemetrexed followed by surgery and adjuvant pembrolizumab in resectable pleural mesothelioma

CHIMERA:一项关于新辅助培美曲塞联合顺铂或卡铂和培美曲塞,随后进行手术及辅助培美曲塞治疗可切除胸膜间皮瘤的II期研究

2026-05-270
OAAI
Dissecting the prognostic role of metabolic markers in lung neuroendocrine Tumors: The MONET study

解析代谢标志物在肺神经内分泌肿瘤中的预后作用:MONET研究

2026-05-230
OAAI
Pathologic assessment of resected stage III non-small cell lung cancer after neoadjuvant chemotherapy: identification of additional prognostic factors

III期非小细胞肺癌新辅助化疗后切除标本的病理评估:识别额外的预后因素

2025-11-090
OAAI
Detection of lung allograft injury through a comprehensive multidisciplinary analysis of donor-derived cell-free DNA in plasma and bronchoalveolar lavage: a real-world single center experience
2025-09-050
OA
Diagnostic significance of intragraft donor-specific anti-HLA antibodies in pulmonary antibody-mediated rejection

移植肺内供者特异性抗-HLA抗体的诊断意义

2025-08-210
PRE
Liver kinase B1 expression is associated with improved prognosis and tumor immune microenvironment features in small cell lung cancer
2025-04-040
OAAI
EGFR status assessment using reflex testing targeted next-generation sequencing for resected non-squamous non-small cell lung cancer
2024-12-311
PRE